 EXFORGE D
|
Siegfried
|
| valsartán+hidrocloroti.+amlodip. |
Antihipertensivo |
| 160/12.5/5 mg comp.x 28 | $68.594,40 | (21/07/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $33.330,11 |
|
|
|
|
| 160/12.5/10 mg comp.x 28 | $67.941,79 | (21/07/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $33.013,00 |
|
|
|
|
| 160/25/5 mg comp.x 28 | $67.992,11 | (21/07/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $33.330,11 |
|
|
|
|
| 160/25/10 mg comp.x 28 | $67.992,11 | (21/07/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $33.330,11 |
|
|
|
|
| 320/25/10 mg comp.x 28 | $71.905,46 | (21/07/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $35.248,46 |
|
|
|
|
| |
